Israel Englander Bluebird Bio, Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
SELL
$3.14 - $8.22 $7,222 - $18,906
-2,300 Reduced 0.92%
247,700 $788,000
Q4 2022

Feb 14, 2023
BUY
$5.77 - $8.49 $867,230 - $1.28 Million
150,300 Added 150.75%
250,000 $1.73 Million
Q3 2022

Nov 14, 2022
BUY
$3.75 - $7.39 $250,125 - $492,913
66,700 Added 202.12%
99,700 $631,000

Others Institutions Holding BLUE

# of Institutions
159
Shares Held
79.9M
Call Options Held
525K
Put Options Held
634K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $35.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email